Expanding Care with Precision Medicine

Send us a textGenetic insights provide valuable information on the best way to approach a patient. In this episode, Jessica Gibson, CEO and Co-Founder of Ariel Precision Medicine, talks about how they leverage years of genetics data and AI technology to deliver precision medicine, particularly in metabolic and gastrointestinal diseases like pancreatitis and diabetes. Jessica felt discontent with the industry’s traditional reactive sick care approach and developed her interest in a proactive, preventative, precise method with better results. Ariel uses patients’ genetic insights to understand what drives their symptoms and identify the best treatments, interventions, or medications, saving them time, costs, and discomfort. She also discusses how the company addresses interoperability issues with the SNaP-SHOT platform. This powerful tool will allow a broader deployment of the precision medicine approach within the physician network outside of the specialized academic care centers.  Tune in to learn about precision medicine and its potential in care delivery!See More ChalkTalkJim Episodes

There are no comments yet.

Please log in to write the first comment.